LivingGLP1
Study S002073

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

ClinicalTrials.gov record

Registration

Registration
NCT00566813
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE1; PHASE2
Masking
NONE
Status
COMPLETED
Enrollment
10
Start
2004-11
Primary completion
2010-07-05
Lead sponsor
University of Illinois at Chicago
Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG:Islet Cell Transplant; DRUG:Islet Cell Transplant plus
Results posted
TRUE
Individual participant data sharing
NO

Registered primary outcomes

  • Number of Participants With Adverse Events Including Laboratory Abnormalities at the End of Study Participation [15 months after the last transplant]
  • Number of Participants With Insulin Independence at End of Study Participation [End of 15 Month Study Participation/Follow-up]
  • Number of Participants With HbA1c Less Than or Equal to 6.5 & Free of Severe Hypoglycemic Events [At end of 15 month study participation]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0027847Islet transplantation for brittle type 1 diabetes: the UIC protocol.
Gangemi A, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
2008ProtocolPMID 18444920DOIregistry reference RESULT:18444920